- Home
- MMYT vs QGEN Comparison
MMYT vs QGEN Comparison
Compare MMYT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMYT
- QGEN
- Stock Information
- Founded
- MMYT 2000
- QGEN 1986
- Country
- MMYT India
- QGEN Netherlands
- Employees
- MMYT N/A
- QGEN N/A
- Industry
- MMYT Transportation Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMYT Consumer Discretionary
- QGEN Health Care
- Exchange
- MMYT Nasdaq
- QGEN Nasdaq
- Market Cap
- MMYT 9.0B
- QGEN 10.7B
- IPO Year
- MMYT 2010
- QGEN 1996
- Fundamental
- Price
- MMYT $74.35
- QGEN $44.31
- Analyst Decision
- MMYT Strong Buy
- QGEN Buy
- Analyst Count
- MMYT 3
- QGEN 7
- Target Price
- MMYT $120.00
- QGEN $50.68
- AVG Volume (30 Days)
- MMYT 1.4M
- QGEN 1.3M
- Earning Date
- MMYT 10-28-2025
- QGEN 11-04-2025
- Dividend Yield
- MMYT N/A
- QGEN 3.40%
- EPS Growth
- MMYT N/A
- QGEN 331.20
- EPS
- MMYT 0.69
- QGEN 1.84
- Revenue
- MMYT $1,011,011,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- MMYT $20.31
- QGEN $7.37
- Revenue Next Year
- MMYT $19.80
- QGEN $5.65
- P/E Ratio
- MMYT $107.50
- QGEN $24.00
- Revenue Growth
- MMYT 14.55
- QGEN 5.32
- 52 Week Low
- MMYT $72.94
- QGEN $37.63
- 52 Week High
- MMYT $123.00
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- MMYT 29.37
- QGEN 40.58
- Support Level
- MMYT $76.02
- QGEN $42.82
- Resistance Level
- MMYT $78.15
- QGEN $45.36
- Average True Range (ATR)
- MMYT 2.70
- QGEN 1.08
- MACD
- MMYT -0.10
- QGEN -0.09
- Stochastic Oscillator
- MMYT 15.67
- QGEN 33.04
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).